Schischk, has been reported to have anti-5-LOX activity, suggesting that SOG might have therapeutic effects on inflammatory disease, such as acute lung injury and RA (Zhao et al., 2016; Liu et al., 2020). This evidence concerns the gene ALOX5 and rheumatoid arthritis.